Business News Agency July 5th News At the Shanghai CPhI International API Exhibition held recently, the vitamin C (VC) industry that the industry has been paying close attention to has new developments. On the one hand, several major VC manufacturers in China have stopped product quotations and look forward to policies. The introduction of the product stimulated the price of the product. However, on the other hand, some small and medium-sized manufacturers are still trying to ship at a low price, in an attempt to “fish out” the last one before the policy goes down.

Since the beginning of the second quarter, almost all products of the vitamin family have entered the channel of rising export prices, but only the VC's former price is still very embarrassing. The main reason is that the VC product is still a serious product. After the rest, the market supply was disorderly and the related rectification policies had not yet been introduced.

At present, the policies awaited by large manufacturers are the rectification policies formulated by the Ministry of Industry and Information Technology of the National Development and Reform Commission regarding the production of compliant companies, compliance production capacity, and production plans. Recent sources revealed that the policy will be formally launched in August.

According to the general direction of the policy, some “non-compliant” companies will surely be eliminated. Some analysts believe that this will include some new production lines that have been heavily invested, and how these capacities will be handled by the time yet to be determined. At the same time, the industry is generally concerned about the criteria for "compliance" and the allocation of production capacity.

In an interview with the reporter, the director of the western medicine department of the Medicare Chamber of Commerce said that the market as a whole is still in a wait-and-see attitude. Since the beginning of last year, the stock on the international market has been more, and the volume of dealers is also very abundant. Buyers will not be anxious. It is estimated that the market will not change much in the near future.

Health Network monitoring showed that VC export prices slightly increased to 5.3 to 5.5 US dollars/kg before the CPhI International API Exhibition. Talking about Shengcai, according to this price, SMEs do not have much room for profit. A large-scale VC manufacturer in China stated at the exhibition that the price of VC may be slightly adjusted in the second half of the year, but it will not change much. In the face of low prices, the company will continue to “stick to the end”.

It should be pointed out that VC prices and market trends are mainly determined by the amount of international supply. Even if the policy finally establishes 10 "compliance" production enterprises, whether or not there is finally a balance between supply and demand still has many uncertainties, such as limited production or Production plan management. Therefore, the policy will have a certain boosting effect on the market's psychology, but it cannot completely change the status quo of the market. The final decision-making power is still in the hands of “compliance” companies. The tacit understanding and self-discipline of enterprises guarantee that this only has international The key to the continued splendor of the right to speak products, so the second half of the VC industry situation is still suspense.